COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,946 Articles (22,604 medRxiv, 8,342 bioRxiv)

Most recent first Previous |  Page 12: Articles 111-120  | Next

Machine-learning strategy for high error tolerance in image-based digital molecular assays
McAffee, D. B., Hu, Q., Arnob, A., Wu, H.-J., Groves, J. T.
10.1101/2025.08.14.670347 — Posted: 2025-08-18
Modeling the Dynamics of COVID-19: Model With Patients With Underlying Conditions.
Magak, G. O., Kagunda, J., Ronoh, M.
10.1101/2025.08.14.25332881 — Posted: 2025-08-16
Changes in Pediatric RSV Hospitalizations after the COVID-19 Pandemic, 2022-2023, Canada: An Active Surveillance Study
Lopes, A., Embree, J., Jadavji, T., Kazmi, K., Langley, J. M., Lebel, M. H., Le Saux, N., Moore, D., Morris, S. K., Pernica, J. M., Robinson, J., Sadarangani, M., Shulha, H., Bettinger, J., Papenburg, J.
10.1101/2025.08.13.25333142 — Posted: 2025-08-15
Variant effect prediction with reliability estimation across priority viruses
Gurev, S., Youssef, N., Jain, N., Marks, D.
10.1101/2025.08.04.668549 — Posted: 2025-08-15
Cross-Neutralizing Monoclonal Antibodies with Broad Activity Against Human and Bat-Derived SARS-Related Coronaviruses
Mayora Neto, M., da Costa, K., Cantoni, D., Derveni, M., Wright, E., Hoschuetzky, H., Kaufmann, F., Schuessler, P., Temperton, N. J.
10.1101/2025.08.14.670296 — Posted: 2025-08-14
A Mouse Model of SARS-CoV-2-Driven Acute Maladaptive Responses and Chronic Systemic Diseases
Kenney, D., Unali, G., Tseng, A. E., Leger, J., Matsuo, M., O'Connell, A. K., McCooney, C., Good, S., Norton, J., Feitosa-Suntheimer, F., Carossino, M., Gertje, H. P., Klose, A., Paragas, N., Francis, K. P., Snyder-Cappione, J. E., Belkina, A., Welcker, J., Albrecht, K., Corley, R. B., Harly, C., Crossland, N. A., Douam, F.
10.1101/2025.08.13.670105 — Posted: 2025-08-13
School masking and COVID-19 community transmission: a synthetic control study
Luan, X., Fisher, B. T., Coffin, S. E., Rubin, D., Meredith, M., Huang, J.
10.1101/2025.08.11.25333446 — Posted: 2025-08-13
Luzon, Visayas, and Mindanao (LuzViMin) During COVID-19: Comparative Analysis on Epidemiology, Pandemic Mobility and Evolutionary Dynamics in the Three Major Islands in the Philippines
Limbo, J. A. B., Madrigal, A. V., Lim, G. I. C., Jingco, L. M. S., Aligato, J. K. D., Cipriano, R. C., Cabildo, K. P. E., Allosa, E. M. C., Manrique, A. F. D., Dungo, D. J. H., Recio, A. D. R., Manzano, J. A. H., Austriaco OP, N.
10.1101/2025.08.07.25333229 — Posted: 2025-08-13
The Impact of National Context on COVID-19 Vaccine Hesitancy Across Europe: A Multi-Level Approach
Bergmann, M., Bethmann, A., Hannemann, T.-V., Schumacher, A., Theodoropoulos, N.
10.1101/2025.08.11.25333435 — Posted: 2025-08-13
Incidence of Long COVID Following Reinfection with COVID-19
Brannock, M. D., Hadley, E., Preiss, A., Fitzgerald, M. L., Jain, N., Taylor, E., Wylam, A., Yoo, Y. J., Hill, E., Moffitt, R. A., N3C Consortium, , RECOVER Consortium
10.1101/2025.08.12.25333155 — Posted: 2025-08-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).